OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes
Xiaoying Zhou, Huixia Lu, Miaomiao Sang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Xiaoying Zhou, Huixia Lu, Miaomiao Sang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)
G Molnár, Zoltán Vokó, Gábor Sütő, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 1, pp. e003777-e003777
Open Access | Times Cited: 6
G Molnár, Zoltán Vokó, Gábor Sütő, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 1, pp. e003777-e003777
Open Access | Times Cited: 6
Relation of myocardial dysfunction to biomarkers, COVID‐19 severity and all‐cause mortality
Jianxiong Chen, Lin Jin, Mengjiao Zhang, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 5, pp. 2954-2966
Open Access | Times Cited: 3
Jianxiong Chen, Lin Jin, Mengjiao Zhang, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 5, pp. 2954-2966
Open Access | Times Cited: 3
Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China
Jianqiao Li, Jiawei Xu, Yu Liu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Jianqiao Li, Jiawei Xu, Yu Liu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Incidence of SARS-CoV-2 infection in children shortly after ending zero-COVID-19 policy in China on December 7, 2022: a cross-sectional, multicenter, seroepidemiological study
Yi‐Hua Zhou, Chenyu Xu, Yue Tao, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4
Yi‐Hua Zhou, Chenyu Xu, Yue Tao, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4
Adverse Effects Reported and Insights Following Sinopharm COVID-19 Vaccination
Alireza Mohebbi, Majid Eterafi, Nasrin Fouladi, et al.
Current Microbiology (2023) Vol. 80, Iss. 12
Closed Access | Times Cited: 3
Alireza Mohebbi, Majid Eterafi, Nasrin Fouladi, et al.
Current Microbiology (2023) Vol. 80, Iss. 12
Closed Access | Times Cited: 3
Uncoupling of the center-to-periphery arterial stiffness gradient and pulse pressure amplification in viral pneumonia infection
Lin Jin, Lingheng Wu, Jianxiong Chen, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Lin Jin, Lingheng Wu, Jianxiong Chen, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Research Progress on the Weak Immune Response to the COVID-19 Vaccine in Patients with Type 2 Diabetes
Shiqi Yuan, Wenwen He, Bin Liu, et al.
Viral Immunology (2024) Vol. 37, Iss. 2, pp. 79-88
Closed Access
Shiqi Yuan, Wenwen He, Bin Liu, et al.
Viral Immunology (2024) Vol. 37, Iss. 2, pp. 79-88
Closed Access
High SARS-CoV-2 infection rate in children unvaccinated with COVID-19 vaccine in Changzhou, China, shortly after lifting zero-COVID-19 policy in December 2022
Jie Tang, Yong Wang, Weiqin Lu, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Jie Tang, Yong Wang, Weiqin Lu, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
How does geographical diversity shape vaccine efficacy?
Mohammad Abavisani, Bahareh Ansari, Negar Ebadpour, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 4, pp. 271-271
Open Access
Mohammad Abavisani, Bahareh Ansari, Negar Ebadpour, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 4, pp. 271-271
Open Access
